Detalhe da pesquisa
1.
Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs.
Ann Hematol
; 99(4): 867-875, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32036421
2.
Brentuximab vedotin in association with bendamustine in refractory or multiple relapsed Hodgkin lymphoma. A retrospective real-world study.
Eur J Haematol
; 104(6): 581-587, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32107795
3.
Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen.
Br J Haematol
; 172(1): 111-21, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26458240
4.
High-Dose Melphalan Plus Thiotepa as Conditioning Regimen before Second Autologous Stem Cell Transplantation for "De Novo" Multiple Myeloma Patients: A Phase II Study.
Biol Blood Marrow Transplant
; 21(11): 1932-8, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26099830
5.
Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study.
Cancers (Basel)
; 14(23)2022 Nov 27.
Artigo
Inglês
| MEDLINE | ID: mdl-36497328
6.
Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience.
Front Oncol
; 11: 740079, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34616684
7.
Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi.
J Geriatr Oncol
; 11(1): 37-40, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31296461
8.
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network.
J Clin Med
; 8(6)2019 Jun 19.
Artigo
Inglês
| MEDLINE | ID: mdl-31248142
9.
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
Leuk Lymphoma
; 53(3): 406-10, 2012 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21916526
10.
Palonosetron (Aloxi) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapy.
Support Care Cancer
; 17(2): 205-9, 2009 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-18839220
11.
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
J Clin Oncol
; 27(5): 805-11, 2009 Feb 10.
Artigo
Inglês
| MEDLINE | ID: mdl-19124807